Universal Biosensors surges 60% on FDA approval for Class II device
Universal Biosensors shares surged 60% following the attainment of US Food and Drug Administration and Clinical Laboratory Improvement Amendments Waiver approvals.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
ERD | Ann: EROAD Investor Call Details - Meet the Dual-CEOs | 07/03/24 | 0 | 58 | |||
|
|||||||
ERD | Ann: Change in Substantial Shareholding from AEF | 06/03/24 | 0 | 55 | |||
|
|||||||
ERD | Ann: EROAD Doubles Down with Introduction of Dual-CEOs | 05/03/24 | 0 | 61 | |||
|
|||||||
ERD | Ann: SPH Notice - Steven Newman and NMC Trustees Limited | 18/01/24 | 0 | 102 | |||
|
|||||||
ERD | Ann: Capital Change Notice - Issue of Performance Share Rights | 07/12/23 | 0 | 90 | |||
|
|||||||
ERD | Ann: Disciplined execution delivers positive HY24 results | 04/12/23 | 1 | 232 | |||
|
|||||||
ERD | Ann: EROAD uses Microsoft Azure OpenAI to accelerate Product Dev | 28/11/23 | 0 | 79 | |||
|
|||||||
ERD | Ann: Capital Change Notice - Issue of Performance Share Rights | 23/11/23 | 0 | 82 | |||
|
See All Discussions